Physician profile
Timothy Wolfe
NPI 1437458635
$961.92
in general payments reported to CMS, 2019-2025
14 companies · $89.65 in 2025
The $89.65 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $77.93 · 2021: $33.98 · 2022: $364 · 2023: $195 · 2024: $201 · 2025: $89.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $413.49 | 2020-2025 | Lifevest |
| Abbvie INC. | $213.92 | 2022-2025 | Teflaro |
| Novartis Pharmaceuticals Corporation | $58.62 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.65 | 2022 | |
| Janssen Pharmaceuticals, INC | $47.32 | 2022 | |
| Boston Scientific Corporation | $31.09 | 2022 | |
| Cvrx, INC. | $28.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.80 | 2024 | Eliquis |
| Kestra Medical Technology Services, INC. | $18.73 | 2024 | Assure Wcd |
| Janssen Scientific Affairs, LLC | $16.18 | 2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $16.11 | 2021 | |
| Pfizer INC. | $13.70 | 2022 | |
| Allergan, INC. | $13.47 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.